Is Pertuzumab produced in China?

It is understood that Pertuzumab (Pertuzumab) has not yet been produced and marketed in China. Pertuzumab sold in China is an imported drug. It is a monoclonal antibody originally produced by Roche Pharmaceuticals and can inhibit human epidermal growth factor receptor 2(H). ER2) dimerizes with other HER receptors, thereby preventing them from signaling in a manner that promotes cell growth and proliferation, and can be administered intravenously in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not previously received anti-HER2 therapy or chemotherapy for metastatic disease. It is also indicated for neoadjuvant treatment of HER2-positive locally advanced, inflammatory or early-stage breast cancer as part of a complete treatment regimen and as adjuvant treatment in patients with HER2-positive early-stage breast cancer who are at high risk of recurrence.